Dietary Changes in Fasting Levels of Factor VII Coagulant Activity (FVII: C) Are Accompanied by Changes in Factor VII Protein and other Vitamin K-dependent Proteins

Summary

The mechanisms behind dietary effects on fasting coagulant activity of factor VII (FVII: C) are not clarified. In the present study of 15 young volunteers, two experimental diets differing in composition of saturated fatty acids (C18:0 [diet S] or C12:0 + C14:0 [diet ML]) were served for 3 weeks each. Fasting blood samples were collected before and after the dietary regimen and analysed for triglycerides, FVII:C, and protein concentrations of FVII, FII, FX, protein C, CRP, albumin, fibrinogen, and F1+2. FVII:C was significantly reduced on diet S compared with diet ML. This was accompanied by a decrease in FVII protein, F1+2 and the vitamin K-dependent proteins FII, FX, and protein C. In contrast, no changes were observed in triglycerides, FVII:C/FVII: Ag, albumin and CRP. Fibrinogen was increased on diet S compared with diet ML. Our findings suggest that the change in fasting FVII:C was part of a general change in concentrations of vitamin K-dependent proteins.

• References

• 1 Meade TW, Brozovic M, Chakrabarti R, Haines AP, Imeson JD, Mellows S, Miller GJ, North WR S, Stirling Y, Thompson SG. Haemostatic function and cardiovascular death: Principal results of The Northwick Park Heart Study. Lancet 1986; 2: 533-537
• 2 Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. 1 1993; 342: 1076-1079
• 3 Haines AP, Chakrabarti R, Fisher D, Meade TW, North WR S, Stirling Y. Haemostatic variables in vegetarians and non-vegetarians. Thromb Res 1980; 19: 139-148
• 4 Miller GJ, Martin JC, Webster J, Wilkes H, Miller NE, Wilkinson WH, Meade TW. Association between dietary fat intake and plasma factor VII coagulant activity - A predictor of cardiovascular mortality. Atherosclerosis 1986; 60: 269-277
• 5 Miller GJ, Cruickshank JK, Ellis LJ, Thompson RL, Wilkes HC, Stirling Y, Mitropoulos KA, Allison JV, Fox TE, Walker AO. Fat consumption and factor VII coagulant activity in middle-aged men. Atherosclerosis 1989; 78: 19-24
• 6 Marckmann P, Sandström B, Jespersen J. Effects of total fat content and fatty acid composition in diet on factor VII coagulant activity and blood lipids. Atherosclerosis 1990; 80: 227-233
• 7 Marckmann P, Jespersen J, Leth T, Sandstrom B. Effect of fish diet versus meat diet on blood lipids, coagulation and fibrinolysis in healthy young men. J Int Med 1991; 229: 317-323
• 8 Miller GJ, Martin JC, Mitropoulos KA, Reeves BE A, Thompson RL, Meade TW, Cooper JA, Cruickshank JK. Plasma factor VII is activated by postprandial triglyceridaemia, irrespective of dietary fat composition. Atherosclerosis 1991; 86: 163-171
• 9 Slabber M, Barnard HC, Kuyl JM, Badenhorst CJ. Effect of a short-term very low calorie diet on plasma lipids, fibrinogen, and factor VII in obese subjects. Clin Biochem 1992; 25: 334-335
• 10 Marckmann P, Sandström B, Jespersen J. Dietary effects on circadian fluctuations in human blood coagulation factor VII and fibronolysis. Atherosclerosis 1993; 101: 225-234
• 11 Marckmann P, Sandstrom B, Jespersen J. Favorable long-term effect of a low-fat/high-fiber diet on human blood coagulation and fibrinolysis. Arteriosclerosis and Thrombosis 1993; 13: 505-511
• 12 Tholstrup T, Marckmann P, Jespersen J, Sandström B. A fat high in stearic acid favorably affects blood lipids and factor VII coagulant activity in comparison to fats high in palmitic acid and high in myristic acid. Am J Clin Nutr 1994; 59 (02) 371-377
• 13 Marckmann P, Sandstrom B, Jespersen J. Low-fat high-fiber diet favorably affects several independent risk markers of ischemic heart disease. Observations on blood lipids, coagulation, and fibrinolysis from a trial of middle- aged Danes Am J Clin Nutr 1994; 59: 935-939
• 14 Bladbjerg EM, Marckmann P, Sandström B, Jespersen J. Non-fasting factor VII coagulant activity (FVII:C) increased by high-fat diet. Thromb Haemost 1994; 71: 755-758
• 15 Silveira A, Karpe F, Blombäck M, Steiner G, Walldius G, Hamsten A. Activation of coagulation factor VII during alimentary lipemia. Arterioscler Thromb 1994; 14: 60-69
• 16 Plu-Bureau G, Scarabin PY, Bara L, Malmejac A, Guize L, Samama M. Factor VII activation and oral contraceptives. Thromb Res 1993; 70: 275-280
• 17 Suzuki T, Yamauchi K, Matsushita T, Furumichi T, Furui H, Tsuzuki J, Saito H. Elevation of factor VII activity and mass in coronary artery disease of varying severity. Clin Cardiol 1991; 14: 731-736
• 18 De Sousa JC, Bruckert E, Giral P, Soria C, Chapman J, Truffert J, Dairou F, De Gennes JL, Caen JP. Coagulation factor VII and plasma triglycerides. Haemostasis 1989; 19: 125-130
• 19 Bruckert E, de Sousa JC, Giral P, Soria C, Chapman MJ, Caen J, de Gennes JL. Interrelationship of plasma triglyceride and coagulant factor VII levels in normotriglyceridemic hypercholesterolaemia. Atherosclerosis 1989; 75: 129-134
• 20 De Sousa JC, Bruckert E, Giral P, Soria C, Truffert J, Mirshahi MC, de Gennes JL, Caen JP. Plasma factor VII, triglyceride concentration and fibrin degradation products in primary hyperlipidaemia: A clinical and laboratory study. Haemostasis 1989; 19: 83-90
• 21 Hoffman C, Shah A, Sodums M, Hultin MB. Factor VII activity state in coronary artery disease. J Lab Clin Med 1988; 111: 475-481
• 22 De Sousa JC, Bruckert E, Soria C, Caen JP. Phospholipase C sensitive factor VII activity and factor VII antigen in hypertriglyceridaemia. Nouv Rev Fr hematol 1989; 31: 13-15
• 23 Hoffman CJ, Miller RH, Lawson WE, Hultin MB. Elevation of factor VII activity and mass in young adults at risk of ischaemic heart disease. JACC 1989; 14: 941-946
• 24 De Sousa JC, Azevedo J, Soria C, Barros F, Ribeiro C, Parreira F, Caen JP. Factor VII hyperactivity in acute myocardial thrombosis. A relation to the coagulation activation Thromb Res 1988; 51: 165-173
• 25 Miller GJ, Walter SJ, Stirling Y, Thompson SG, Esnouf MP, Meade TW. Assay of factor VII activity by two techniques: evidence for increased conversion of FVII to FVIIa in hyperlipidaemia, with possible implications for ischaemic heart disease. Br J Haematol 1985; 59: 249-258
• 26 Hultin MB. Fibrinogen and factor VII as risk factors in vascular disease. Prog Hemost Thromb 1991; 10: 215-241
• 27 Bums P, Hoffman CJ, Katz JP, Miller RH, Lawson WE, Hultin MB. Vitamin K-dependent clotting factors are elevated in young adults who have close relatives with ischemic heart disease. J Lab Clin Med 1993; 122: 720-727
• 28 Poller L, Thomson J. The Manchester comparative reagent. A national reference standard for anticoagulant therapy. In Human blood coagulation. Chapter III: Laboratory methods. Hemker HC, Loeliger EA, Veltkamp JJ. eds. Leiden: University Press: 1969. pp 290-295
• 29 Kitchen S, Malia RG, Preston FE. A comparison of methods for the measurement of activated factor VII. Thromb Haemost 1992; 68 (03) 301-305
• 30 Laurell CB. Electroimmuno Assay. Scan J Clin Lab Invest 1972; 29 Suppl (Suppl. 124) 21
• 31 Mitropoulos KA, Esnouf MP. The prothrombin activation peptide regulates synthesis of the vitamin K-dependent proteins in the rabbit. Thromb Res 1990; 57: 541-549
• 32 Mitropoulos KA, Reeves BE A, Miller GJ. The activation of factor VII in citrated plasma by charged long-chain saturated fatty acids at the interface of large triglyceride-rich lipoproteins. Blood Coag Fibrinol 1993; 4: 943-951
• 33 Mitropoulos KA, Miller GJ, Martin JC, Reeves BE A, Cooper J. Dietary fat induces changes in factor VII coagulant activity through effects on plasma free stearic acid concentration. Arterioscler Thromb 1994; 14: 214-222
• 34 Elovson J. Conversions of palmitic and stearic acid in the intact rat. Bio- chim Biophys Acta 1965; 106: 291-303
• 35 Bonanome A, Bennett M, Grundy SM. Metabolic effects of dietary stearic acid in mice: changes in the fatty acid composition of triglycerides and phospholipids in various tissues. Atherosclerosis 1992; 94: 119-127
• 36 Emken EA, Adlof AO, Rohwedder WK, Gulley RM. Influence of linoleic acid on desaturation and uptake of deuterium-labeled palmitic and stearic acids in humans. Biochim Biophys Acta 1993; 1170: 173-181
• 37 De Sousa JC, Soria C, Ayrault-Jarrier M, Pastier D, Bruckert E, Amiral J, Bereziat G, Caen JP. Association between coagulation factor VII and X with triglyceride rich lipoproteins. J Clin Pathol 1988; 41: 940-944
• 38 Constantino M, Merskey C, Kudzma DJ, Zucker MB. Increased activity of vitamin K-dependent clotting factors in human hyperlipoproteinaemia - Association with cholesterol and triglyceride levels. Thromb Haemost 1977; 38: 465-474
• 39 Mori Y, Wada H, Nagano Y, Deguchi K, Kita T, Shirakawa S. Hyper- coagulable state in the Watanabe heritable hyperlipidemic rabbit, an animal model for the progression of atherosclerosis. Thromb Haemost 1989; 61: 140-143
• 40 Elkeles RS, Chakrabarti R, Vickers M, Stirling Y, Meade TW. Effect of treatment of hyperlipidaemia on haemostatic variables. Br Med J 1980; 281: 973-974
• 41 Simpson HC R, Meade TW, Stirling Y, Mann JI, Chakrabarti R, Woolf L. Hypertriglyceridaemia and hypercoagulability. Lancet 1983; 1: 786-789
• 42 Ferland G, Sadowski JA, O’Brien ME. Dietary induced subclinical vitamin K deficiency in normal human subjects. J Clin Invest 1993; 91: 1761-1768
• 43 Pickart L. Fat metabolism, the fibrinogen/fibrinolytic system and blood flow: new potentials for the pharmacological treatment of coronary heart disease. Pharmacology 1981; 23: 271-280
• 44 Miller GJ, Wilkes HC, Meade TW, Bauer KA, Barzegar S, Rosenberg RD. Haemostatic changes that constitute the hypercoagulable state. Lancet 1991; 338: 1079